Skip to main navigation Skip to search Skip to main content

Age-dependent TDP-43-mediated motor neuron degeneration requires GSK3, hat-trick, and xmas-2

Research output: Contribution to journalArticlepeer-review

Abstract

The RNA-processing protein TDP-43 is central to the pathogenesis of amyotrophic lateral sclerosis (ALS), the most common adult-onset motor neuron (MN) disease [1-4]. TDP-43 is conserved in Drosophila, where it has been the topic of considerable study, but how TDP-43 mutations lead to age-dependent neurodegeneration is unclear and most approaches have not directly examined changes in MN morphology with age [5]. We used a mosaic approach to study age-dependent MN loss in the adult fly leg where it is possible to resolve single motor axons, NMJs and active zones, and perform rapid forward genetic screens. We show that expression of TDP-43Q331K caused dying-back of NMJs and axons, which could not be suppressed by mutations that block Wallerian degeneration. We report the identification of three genes that suppress TDP-43 toxicity, including shaggy/GSK3, a known modifier of neurodegeneration [6]. The two additional novel suppressors, hat-trick and xmas-2, function in chromatin modeling and RNA export, two processes recently implicated in human ALS [7, 8]. Loss of shaggy/GSK3, hat-trick, or xmas-2 does not suppress Wallerian degeneration, arguing TDP-43Q331K-induced and Wallerian degeneration are genetically distinct processes. In addition to delineating genetic factors that modify TDP-43 toxicity, these results establish the Drosophila adult leg as a valuable new tool for the in vivo study of adult MN phenotypes.

Original languageEnglish (US)
Pages (from-to)2130-2136
Number of pages7
JournalCurrent Biology
Volume25
Issue number16
DOIs
StatePublished - Aug 17 2015
Externally publishedYes

Funding

We thank Dr. Stephan Züchner and Dr. Michael Gonzalez for fly whole-genome sequencing; Dr. Matthew White, Dr. Ru-Ju Chian, Sivakumar Boopathy, Amy Sheehan, and Jonathan Farley for technical assistance; and Dr. Michael Coleman, Dr. Zuoshang Xu, and all members of the M.R.F. and R.H.B. labs for helpful discussions and critical appraisal of this work. We are grateful to the following investigators for providing Drosophila stocks and reagents: Dr. Fen-Biao Gao, Dr. Vivian Budnik, Dr. Frank Hirth, Dr. Natalia Kopytova, Dr. Stephan Sigrist, and Dr. Haining Zhu. This work was supported by funding from the Medical Research Council, UK, the MNDA Lady Edith Wolfson Fellowship, the Max Rosenfeld Fund (to J.S.), the King Trust Fellowship (to L.J.N.), NIH grant RO1 NS059991 (to M.R.F.), and the ALS Therapy Alliance, and M.R.F. is an Investigator of the Howard Hughes Medical Institute.

FundersFunder number
Elizabeth C. King Trust
MNDA Lady Edith Wolfson Fellowship
Max Rosenfeld Fund
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health
Howard Hughes Medical Institute
National Institute of Neurological Disorders and StrokeR01NS059991
Medical Research Council/Biological Sciences Research Council

    ASJC Scopus subject areas

    • General Biochemistry, Genetics and Molecular Biology
    • General Agricultural and Biological Sciences

    Fingerprint

    Dive into the research topics of 'Age-dependent TDP-43-mediated motor neuron degeneration requires GSK3, hat-trick, and xmas-2'. Together they form a unique fingerprint.

    Cite this